BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rose PE, Armour JA, Williams CE, Hill FG. Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndrome. J Clin Pathol 1985;38:438-41. [PMID: 2859303 DOI: 10.1136/jcp.38.4.438] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Byrnes J, Moake J. 7 Thrombotic Thrombocytopenic Purpura and the Haemolytic-Uraemic Syndrome: Evolving Concepts of Pathogenesis and Therapy. Clinics in Haematology 1986;15:413-42. [DOI: 10.1016/s0308-2261(18)30024-9] [Cited by in Crossref: 68] [Article Influence: 1.9] [Reference Citation Analysis]
2 Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut 1993;34:247-51. [PMID: 8432482 DOI: 10.1136/gut.34.2.247] [Cited by in Crossref: 149] [Cited by in F6Publishing: 152] [Article Influence: 5.1] [Reference Citation Analysis]
3 Park S, Worobo RW, Durst RA. Escherichia coli O157:H7 as an emerging foodborne pathogen: a literature review. Crit Rev Biotechnol 2001;21:27-48. [PMID: 11307844 DOI: 10.1080/20013891081674] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
4 Olusanya O, Steinrück H, Aleljung P, Ascencio F, Curman B, Järnerot G, Wadström T, Ljungh A. Surface properties, connective tissue protein binding and Shiga-like toxin production of Escherichia coli isolated from patients with ulcerative colitis. Zentralbl Bakteriol 1992;276:254-63. [PMID: 1559012 DOI: 10.1016/s0934-8840(11)80012-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
5 Lingwood CA, Law H, Richardson S, Petric M, Brunton JL, De Grandis S, Karmali M. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. Journal of Biological Chemistry 1987;262:8834-9. [DOI: 10.1016/s0021-9258(18)47490-x] [Cited by in Crossref: 234] [Article Influence: 6.7] [Reference Citation Analysis]
6 Karch H, Bitzan M, Pietsch R, Stenger K, von Wulffen H, Heesemann J, Düsing R. Purified verotoxins of Escherichia coli O157:H7 decrease prostacyclin synthesis by endothelial cells. Microbial Pathogenesis 1988;5:215-21. [DOI: 10.1016/0882-4010(88)90024-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
7 Walters MD, Levin M, Smith C, Nokes TJ, Hardisty RM, Dillon MJ, Barratt TM. Intravascular platelet activation in the hemolytic uremic syndrome. Kidney International 1988;33:107-15. [DOI: 10.1038/ki.1988.17] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 1.4] [Reference Citation Analysis]
8 Karpman D, Papadopoulou D, Nilsson K, Sjögren AC, Mikaelsson C, Lethagen S. Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. Blood 2001;97:3100-8. [PMID: 11342436 DOI: 10.1182/blood.v97.10.3100] [Cited by in Crossref: 100] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
9 Barbieri JT, Cooling LLW, Walker KE, Gille T, Koerner TAW. Shiga Toxin Binds Human Platelets via Globotriaosylceramide (P k Antigen) and a Novel Platelet Glycosphingolipid. Infect Immun 1998;66:4355-66. [DOI: 10.1128/iai.66.9.4355-4366.1998] [Cited by in Crossref: 85] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
10 Proulx F, Seidman EG, Karpman D. Pathogenesis of Shiga Toxin-Associated Hemolytic Uremic Syndrome. Pediatr Res 2001;50:163-71. [DOI: 10.1203/00006450-200108000-00002] [Cited by in Crossref: 139] [Cited by in F6Publishing: 126] [Article Influence: 6.6] [Reference Citation Analysis]
11 Ghosh SA, Polanowska-Grabowska RK, Fujii J, Obrig T, Gear AR. Shiga toxin binds to activated platelets. J Thromb Haemost 2004;2:499-506. [PMID: 15009469 DOI: 10.1111/j.1538-7933.2004.00638.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
12 Zoja C, Buelli S, Morigi M. Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction. Pediatr Nephrol 2010;25:2231-40. [DOI: 10.1007/s00467-010-1522-1] [Cited by in Crossref: 127] [Cited by in F6Publishing: 114] [Article Influence: 10.6] [Reference Citation Analysis]
13 Kerrigan SW, Cox D. Platelet-bacterial interactions. Cell Mol Life Sci. 2010;67:513-523. [PMID: 20091082 DOI: 10.1007/s00018-009-0207-z] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 5.9] [Reference Citation Analysis]
14 Ucar A, Fernandez HF, Byrnes JJ, Lian EC, Harrington WJ. Thrombotic microangiopathy and retroviral infections: A 13-year experience. Am J Hematol 1994;45:304-9. [DOI: 10.1002/ajh.2830450407] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 1.8] [Reference Citation Analysis]
15 Siegler RL. The Hemolytic Uremic Syndrome. Pediatric Clinics of North America 1995;42:1505-29. [DOI: 10.1016/s0031-3955(16)40096-9] [Cited by in Crossref: 103] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
16 Goldwater PN, Williams V, Bourne AJ, Byard RW. Sudden infant death syndrome: a possible clue to causation. Medical Journal of Australia 1990;153:59-60. [DOI: 10.5694/j.1326-5377.1990.tb125473.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 0.9] [Reference Citation Analysis]
17 Yagi H, Narita N, Matsumoto M, Sakurai Y, Ikari H, Yoshioka A, Kita E, Ikeda Y, Titani K, Fujimura Y. Enhanced low shear stress induced platelet aggregation by Shiga-like toxin 1 purified from Escherichia coli O157. Am J Hematol 2001;66:105-15. [PMID: 11421288 DOI: 10.1002/1096-8652(200102)66:2<105::AID-AJH1025>3.0.CO;2-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
18 Viisoreanu D, Polanowska-Grabowska R, Suttitanamongkol S, Obrig TG, Gear AR. Human platelet aggregation is not altered by Shiga toxins 1 or 2. Thromb Res 2000;98:403-10. [PMID: 10828480 DOI: 10.1016/s0049-3848(00)00191-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
19 Hunt CM, Harvey JA, Youngs ER, Irwin ST, Reid TM. Clinical and pathological variability of infection by enterohaemorrhagic (Vero cytotoxin producing) Escherichia coli. J Clin Pathol 1989;42:847-52. [PMID: 2671052 DOI: 10.1136/jcp.42.8.847] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
20 Francis DH, Moxley RA, Andraos CY. Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7. Infect Immun 1989;57:1339-42. [PMID: 2647636 DOI: 10.1128/iai.57.4.1339-1342.1989] [Cited by in Crossref: 48] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
21 Bitzan M, Moebius E, Ludwig K, Müller-wiefel DE, Heesemann J, Karch H. High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. The Journal of Pediatrics 1991;119:380-5. [DOI: 10.1016/s0022-3476(05)82049-9] [Cited by in Crossref: 92] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
22 Busca A, Uderzo C. Bone Marrow Transplant Associated Thrombotic Microangiopathy. Hematology 2016;5:53-67. [DOI: 10.1080/10245332.2000.11746488] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
23 Rose P, Clark A. Haematology of the haemolytic uraemic syndrome. Blood Reviews 1989;3:136-40. [DOI: 10.1016/0268-960x(89)90009-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Lichota A, Gwozdzinski K, Szewczyk EM. Microbial Modulation of Coagulation Disorders in Venous Thromboembolism. J Inflamm Res 2020;13:387-400. [PMID: 32801832 DOI: 10.2147/JIR.S258839] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
25 Taylor CM, White RH, Winterborn MH, Rowe B. Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands. Br Med J (Clin Res Ed) 1986;292:1513-6. [PMID: 3087499 DOI: 10.1136/bmj.292.6534.1513] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 2.0] [Reference Citation Analysis]
26 Kavi J, Wise R. Causes of the haemolytic uraemic syndrome. BMJ 1989;298:65-6. [PMID: 2493295 DOI: 10.1136/bmj.298.6666.65] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
27 Shen W, Steinrück H, Ljungh A. Expression of binding of plasminogen, thrombospondin, vitronectin, and fibrinogen, and adhesive properties by Escherichia coli strains isolated from patients with colonic diseases. Gut 1995;36:401-6. [PMID: 7535283 DOI: 10.1136/gut.36.3.401] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
28 Kaplan BS, Vedaranayanan VV. Pathogenesis of the hemolytic uremic syndromes: current concepts. Indian J Pediatr 1988;55:512-25. [DOI: 10.1007/bf02868435] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
29 O’brien AD, Tesh VL, Donohue-rolfe A, Jackson MP, Olsnes S, Sandvig K, Lindberg AA, Keusch GT. Shiga Toxin: Biochemistry, Genetics, Mode of Action, and Role in Pathogenesis. In: Sansonetti PJ, editor. Pathogenesis of Shigellosis. Berlin: Springer Berlin Heidelberg; 1992. pp. 65-94. [DOI: 10.1007/978-3-642-77238-2_4] [Cited by in Crossref: 62] [Cited by in F6Publishing: 137] [Article Influence: 2.1] [Reference Citation Analysis]
30 Guo YL, Liu DQ, Bian Z, Zhang CY, Zen K. Down-regulation of platelet surface CD47 expression in Escherichia coli O157:H7 infection-induced thrombocytopenia. PLoS One 2009;4:e7131. [PMID: 19771158 DOI: 10.1371/journal.pone.0007131] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
31 Jaradat Z, Marquardt R. L-arginine as a therapeutic approach for the verotoxigenic Escherichia coli-induced hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Medical Hypotheses 1997;49:277-80. [DOI: 10.1016/s0306-9877(97)90213-9] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
32 Olah KS, Gee H. Postpartum haemolytic uraemic syndrome precipitated by antibiotics. Case report. BJOG:An international journal of O&G 1990;97:83-6. [DOI: 10.1111/j.1471-0528.1990.tb01722.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
33 Vercellone A, Stratta P, Canavese C. Hemolytic Uremic Syndrome. In: Amerio A, Coratelli P, Campese VM, Massry SG, editors. Acute Renal Failure. Boston: Springer US; 1987. pp. 185-98. [DOI: 10.1007/978-1-4684-8240-9_24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]